Does VINORELBINE Cause Malignant neoplasm progression? 624 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 624 reports of Malignant neoplasm progression have been filed in association with VINORELBINE (Vinorelbine). This represents 12.1% of all adverse event reports for VINORELBINE.
624
Reports of Malignant neoplasm progression with VINORELBINE
12.1%
of all VINORELBINE reports
107
Deaths
110
Hospitalizations
How Dangerous Is Malignant neoplasm progression From VINORELBINE?
Of the 624 reports, 107 (17.1%) resulted in death, 110 (17.6%) required hospitalization, and 17 (2.7%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VINORELBINE. However, 624 reports have been filed with the FAERS database.
What Other Side Effects Does VINORELBINE Cause?
Off label use (644)
Disease progression (526)
Neutropenia (517)
Nausea (504)
Drug ineffective (391)
Fatigue (373)
Diarrhoea (371)
Vomiting (342)
Anaemia (335)
Thrombocytopenia (308)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which VINORELBINE Alternatives Have Lower Malignant neoplasm progression Risk?
VINORELBINE vs VINORELBINE\VINORELBINE
VINORELBINE vs VIREAD
VINORELBINE vs VISIPAQUE
VINORELBINE vs VISMODEGIB
VINORELBINE vs VITAMIN A